Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

Red Cell Alloimmunization and Autoimmunization in Multi-Transfused Thalassemia Patients in Sulaymaniyah Province-Iraq

  • Abdulqader, Aveen M. Raouf (Department of Pathology, College of Medicine, University of Sulaymaniyah) ;
  • Mohammed, Ali Ibrahim (Department of Pathology, College of Medicine, University of Sulaymaniyah) ;
  • Mohammed, Nagham Ibrahim (Ninavah Health Directorate)
  • Received : 2020.04.07
  • Accepted : 2020.04.20
  • Published : 2020.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Thalassemias are considered important health issues throughout Iraq, involving its Kurdistan region. This disorder, particularly its major form, needs lifelong regular transfusions. But this form of medical care is associated with various complications including red cell alloimmunization and autoimmunization. This study determined the frequency and associations of alloimmunization among multi-transfused patients with β-thalassemia major. The subjects were 204 patients who were registered at a thalassemia care center in Sulaymaniyah-Iraqi Kurdistan. The patients' records were analyzed, their red cells were phenotyped for ABO/RhD antigens using the gel card method, and irregular antibody screening/identification was performed using the standard tube method. Alloantibodies were detected in 5.8% of the patients, while DAT was positive in 4% of the patients, which indicated autoantibodies. The identified alloantibodies were anti-E (2.4%), anti-C (1.4%), anti-e (1%), and anti-K (1%). A patient's age at the start of transfusion (>2 years) (P=0.042) and a positive history of transfusion reactions (P=0.003) were correlated with a significantly higher rate of alloantibody formation. From the results of our study, we conclude that measures to decrease the development of alloantibodies may incorporate matching for Rhesus and Kell systems and early induction of blood transfusions.

Keywords

References

  1. Weatherall DJ. The molecular basis for phenotypic diversity of genetic disease. Ann N Y Acad Sci. 1995;758:245-260. http://dx.doi.org/10.1111/j.1749-6632.1995.tb24832.x
  2. Iheanyi EO. Practical management of haemoglobinopathies. 1st ed. Oxford, UK: Blackwell publishing; 2004.
  3. Hamamy HA, Al-Allawi NA. Epidemiological profile of common haemoglobinopathies in Arab countries. J Community Genet. 2013;4:147-167. http://doi.org/10.1007/s12687-012-0127-8
  4. Thedsawad A, Taka O, Wanachiwanawin W. Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias. Hematology. 2019;24:208-214. http://doi.org/10.1080/16078454.2018.1549818
  5. Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V. Guidelines for the management of transfusion dependent thalassaemia (TDT). 3rd ed. Nicosia, Cyprus: Thalassaemia International Federation; 2014.
  6. Ahmed AM, Hasan NS, Ragab SH, Habib SA, Emara NA, Aly AA. Red cell alloimmunization and autoantibodies in Egyptian transfusion-dependent thalassaemia patients. Arch Med Sci. 2010;6:592-598. http://doi.org/10.5114/aoms.2010.14473
  7. Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood. 2000;96:3369-3373. https://doi.org/10.1182/blood.v96.10.3369.h8003369_3369_3373
  8. Hussein E, Desooky N, Rihan A, Kamal A. Predictors of red cell alloimmunization in multitransfused Egyptian patients with b-thalassemia. Arch Pathol Lab Med. 2014;138:684-688. http://doi.org/10.5858/arpa.2013-0016-OA
  9. Chaudhari CN. Red cell alloantibodies in multiple transfused thalassaemia patients. Med J Armed Forces India. 2011;67:34-37. http://doi.org/10.1016/S0377-1237(11)80008-0
  10. Ameen R, Al-Shemmari S, Al-Humood S, Chowdhury RI, Al-Eyaadi O, Al-Bashir A. RBC alloimmunization and autoimmunization among transfusion dependent Arab thalassemia patients. Transfusion. 2003;43:1604-1610. http://doi.org/10.1046/j.1537-2995.2003.00549.x
  11. Pahuja S, Pujani M, Gupta SK, Chandra J, Jain M. Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. Hematology. 2010;15:174-177. http://doi.org/10.1179/102453309X12583347114013
  12. Wang LY, Liang DC, Liu HC, Chang FC, Wang CL, Chan YS, et al. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfusion Med. 2006;16:200-203. http://doi.org/10.1111/j.1365-3148.2006.00656.x
  13. Salama MA, Sadek NA, Hassab HM, Abadeer AF, Mikhael IL. Erythrocyte autoantibodies and expression of CD59 on the surface of red blood cells of polytransfused patients with beta thalassaemia major. Br J Biomed Sci. 2004;61:88-92. http://doi.org/10.1080/09674845.2004.11732650
  14. Shamsian BS, Arzanian MT, Shamshiri AR, Samin A, Khojasteh O. Frequency of red cell alloimmunization in patients with ${\beta}$-major thalassemia in an Iranian referral hospital. Iran J Pediatr. 2008;18:149-153.
  15. Dhawan HK, Kumawat V, Marwaha N, Sharma RR, Sachdev S, Bansal D, et al. Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: study on 319 patients. Asian J Transfus Sci. 2014;8:84-88. http://doi.org/10.4103/0973-6247.137438
  16. Young PP, Uzieblo A, Trulock E, Lublin DM, Goodnough LT. Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia? Transfusion. 2004;44:67-72. http://doi.org/10.1046/j.0041-1132.2003.00589.x
  17. Singhal D, Kutyna M, Chhetri R, Wee L, Hague S, Nath L, et al. Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome. Haematologica. 2017;102:2021-2029. http://doi.org/10.3324/haematol.2017.175752
  18. Hisham AG, Shaema SA, Najmaddin Kh, Muhammad BA. Distribution of red cell antigens according to ABO, Rh and other rare blood group systems in Kurdish ethnicity. Iraqi J Hematology. 2016;5:55-80. http://doi.org/10.3324/haematol.2017.175752
  19. Roback JD, Combs MR, Grossman BJ, et al. Technical manual. 16th ed. Bethesda, MD: AABB; 2008.
  20. Chou ST, Liem RI, Thompson AA. Challenges of alloimmunization in patients with haemoglobinopathies. Br J Haematol. 2012;159:394-404. http://doi.org/10.1111/bjh.12061
  21. Al-Mousawi M, Al-Allawi N, Alnaqshabandi R. Predictors of red cell alloimmunization in Kurdish multi transfused patients with hemoglobinopathies in Iraq. Hemoglobin. 2015;39:426-426. http://doi.org/10.3109/03630269.2015.1077460
  22. Thompson AA, Cunningham MJ, Singer ST, Neufeld EJ, Vichinsky E, Yamashita R, et al. Red cell alloimmunization in a diverse population of transfused patients with thalassaemia. Br J Haematol. 2011;153:121-128. http://doi.org/10.1111/j.1365-2141.2011.08576.x
  23. Obaid JMAS, Abo El-Nazar SY, Ghanem AM, El-Hadidi AS, Mersal BHM. Red blood cells alloimmunization and autoimmunization among transfusion-dependent beta-thalassemia patients in Alexandria province, Egypt. Transfusion and Apheresis Science. 2015;53:52-57. http://doi.org/10.1016/j.transci.2015.03.006
  24. Saied DA, Kaddah AM, Badr Eldin RM, Mohaseb SS. Alloimmunization and erythrocyte autoimmunization in transfusion- dependent Egyptian thalassemic patients. J Pediatr Hematol Oncol. 2011;33:409-414. http://doi.org/10.1097/MPH.0b013e3182208154
  25. Abdelrazik AM, Elshafie SM, El Said MN, Ahmed GME, Al-Gamil AA, El Nahhas MGM, et al. Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt. Transfusion. 2016;56;2303-2307. http://doi.org/10.1111/trf.13695
  26. Jeengar RK, Upadhyaya A, Agarwal N, Mehta A. Red cell alloimmunization in repeatedly transfused children with beta thalassemia major. Int J Contemp Pediatr. 2017;4:775-779. http://doi.org/10.18203/2349-3291
  27. Sahu A, Parida P, Mahapatra S, Sahoo BB. Detection of red cell alloantibodies in thalassaemia patients. Int J Contemp Pediatr. 2020;7:419-423. http://doi.org/10.18203/2349-3291.ijcp20200121
  28. Chao YH, Wu KH, Lu JJ, Shih MC, Peng CT, Chang CW. Red blood cell alloimmunization among Chinese patients with b-thalassaemia major in Taiwan. Blood Transfus. 2013;11:71-74. http://dx.doi.org/10.2450/2012.0153-11